NanoString Investor Relations Material

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics. The company offers scanning probe microarrays for a broad range of applications in various disciplines within the life sciences including genomics, epigenomics, virology, immunology, and medical diagnostics for DNA sequencing and RNA analysis. It also provides technology for microRNA (miRNA) detection offering comprehensive capabilities that support discovery to diagnostic screening; as well as discovery stage to commercialization offerings. In addition, the company offers a portfolio of reagents which are designed to work with its Stable Isotope Labeling by Amino acids in Cell Culture (SILAC) solution or isothermal amplification products to perform cell-based investigations into disease pathogenesis or drug development applications. The company has strategic collaboration agreements with pharmaceutical companies, academic institutions, and clinical research organizations to develop novel methodologies for biological analysis and therapeutic discovery.